TrialThe Lancet. Infectious diseases2016

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.

Aung Pyae Phyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.